Clinical Trial Update: Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes [NA]

View source ↗

Summary

A clinical trial evaluating combined dietary fiber supplementation and biotin to modulate the gut microbiome and optimize bariatric surgery outcomes has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• BIotiN (biotin)
• FibERs (dietary fiber supplement)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Obesity, Metabolic Syndrome | NA | Status: TERMINATED